Balaji Amines Ltd

Balaji Amines Q3 FY26 Results: ₹336 Cr Revenue, 18.34% EBITDA Margin 📊

• Consolidated Q3FY26 revenue: ₹336 crore

• Standalone Q3FY26 revenue: ₹306.57 crore

• Nine months FY26 consolidated total income: ₹1,051.26 crore

• EBITDA margin for consolidated Q3FY26: 18.34% (slightly down from 19.24% in Q2FY26)

• Sales volumes for Q3FY26: Amines 6,993.27 MT, Amines Derivatives 9,222.55 MT, Specialty Chemicals 9,678.27 MT

• Company is debt-free on standalone basis

• New projects include Di Methyl Ether (DME), N-Methyl Morpholine (NMM), and Acetonitrile (ACN) - all expected commissioning in FY2026-27

• Subsidiary plans ₹750 crore expansion for Hydrogen Cyanide and Sodium Cyanide products

• Management cites stable demand despite global uncertainties

• Optimism for export opportunities from EU Free Trade Agreement